Nettelbeck, D.M.; Leber, M.F.; Altomonte, J.; Angelova, A.; Beil, J.; Berchtold, S.; Delic, M.; Eberle, J.; Ehrhardt, A.; Engeland, C.E.;
et al. Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies. Viruses 2021, 13, 1420.
https://doi.org/10.3390/v13081420
AMA Style
Nettelbeck DM, Leber MF, Altomonte J, Angelova A, Beil J, Berchtold S, Delic M, Eberle J, Ehrhardt A, Engeland CE,
et al. Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies. Viruses. 2021; 13(8):1420.
https://doi.org/10.3390/v13081420
Chicago/Turabian Style
Nettelbeck, Dirk M., Mathias F. Leber, Jennifer Altomonte, Assia Angelova, Julia Beil, Susanne Berchtold, Maike Delic, Jürgen Eberle, Anja Ehrhardt, Christine E. Engeland,
and et al. 2021. "Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies" Viruses 13, no. 8: 1420.
https://doi.org/10.3390/v13081420
APA Style
Nettelbeck, D. M., Leber, M. F., Altomonte, J., Angelova, A., Beil, J., Berchtold, S., Delic, M., Eberle, J., Ehrhardt, A., Engeland, C. E., Fechner, H., Geletneky, K., Goepfert, K., Holm, P. S., Kochanek, S., Kreppel, F., Krutzke, L., Kühnel, F., Lang, K. S.,
... Ungerechts, G.
(2021). Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies. Viruses, 13(8), 1420.
https://doi.org/10.3390/v13081420